Funding will accelerate development of next-generation lithium-ion battery technology.
Cambridge Enterprise, University of Cambridge
Cambridge Enterprise exists to help University of Cambridge inventors, innovators and entrepreneurs make their ideas and concepts more commercially successful for the benefit of society, the UK economy, the inventors and the University.
Telephone: +44 (0)1223 760 339
Address :
Hauser Forum 3 Charles Babbage Road Cambridge
Post Code: CB3 0GT
Country: United Kingdom
Website: http://www.enterprise.cam.ac.uk
Membership Type: Cambridge University Department
Cambridge Enterprise offers support to all of the University’s research fields, from science, technology, engineering, maths and medicine to the arts, humanities and social sciences. It is through us that many of the University’s inventions and ideas are protected, licences and consultancy contracts are negotiated, and funding is acquired by start-ups and spin-outs.
There are no Products & Services to display
25-08-2021
Thirteen semi-finalists have been announced for the 2021 Chris Abell Postdoc Business Plan Competition run by Cambridge Enterprise.
30-07-2021
The University of Cambridge announces the appointment of Dr Diarmuid O’Brien as the new Chief Executive of Cambridge Enterprise, effective September 2021.
05-05-2021
University of Cambridge spin-out company HexagonFab today announced a £1.9 million seed funding round, led by Cambridge Enterprise, joined by Parkwalk, New Grounds VC, Silicon Valley-based R42 Group, and several private investors.
20-04-2021
ENECHANGE has acquired 100% of share capital and acquisition rights in SMAP Energy, making the company a wholly owned subsidiary.
30-03-2021
Cambridge GaN Devices (CGD) has raised $9.5 million in Series A funding. The investment was co-led by IQ Capital, Parkwalk Advisors, and BGF and joined by Cambridge Enterprise, Foresight Williams, Martlet Capital, Cambridge Angels, and Cambridge Capital Group. CGD will use the funding to expand its product portfolio of energy-efficient power devices and to double the size of its team.
18-02-2021
ApcinteX, Morphogen-IX, Z Factor join seven other privately held biotech companies in a new type of pharmaceutical R&D model.
17-02-2021
The University of Cambridge has launched its eighth Enterprise Fund, managed by university spinout fund manager Parkwalk in conjunction with Cambridge Enterprise, the University’s Technology Transfer Office.
10-02-2021
ApcinteX Ltd, a biotech company spun out of the University of Cambridge, today announced the results from Part I of its ongoing clinical trial, AP-0101, assessing the safety, tolerability, and pharmacokinetics of its investigational drug SerpinPC in healthy volunteers and patients with severe haemophilia A and B.
05-02-2021
GlycoVue, which combines glucose-responsive smart polymers with advanced holography and AI-enabled smartphone technology for diabetes self-management, has won the £20,000 first prize in the 2020 Cambridge Enterprise Postdoc Business Plan Competition.
19-11-2020
Psyomics Ltd, a UK-based healthtech and University of Cambridge spin-out, has closed a £1.5 million funding round from existing and new investors to bring its mental health assessment and diagnosis platform, Censeo, to market in the UK. University spinout specialists Parkwalk led the round, joined by fellow existing investors Jonathan Milner, Martlet, and Cambridge Enterprise.
27-10-2020
A former board member of one of the world’s biggest companies and White House climate change advisor has joined a Cambridge University start-up making plastic from peas.
21-10-2020
Z Factor Ltd, a Cambridge-based drug development company spun out of the University of Cambridge, announced that the first human volunteer was dosed today with ZF874, its novel treatment for alpha-1-antitrypsin deficiency (AATD).
19-08-2020
Bond180, a provider of technology solutions for primary fixed income markets, has announced completion of a strategic funding round. The round involved follow-on investment from Cambridge Enterprise, joined by technology partners, strategic angels, and venture investors.
21-07-2020
Research England has awarded two grants, totalling £1.5 million, to support two programmes working to dramatically increase the economic value and social impacts derived from university research, both internationally and in the UK. The funds will be administered by the University of Cambridge.
16-07-2020
PharmEnable, a Cambridge-based drug discovery company using advanced medicinal chemistry and AI-enabled approaches to design the next generation of highly complex and specific drug candidate molecules, announces it has closed a £1.8 million seed financing to support its transition into a drug development company.
30-06-2020
Semiconductor company Flusso has raised a $5.7 million Series A funding round to scale up production of the world’s smallest flow sensor. The round was led by existing investor Parkwalk Advisors and new investor Foresight Williams Technology EIS Fund, with participation from Cambridge Enterprise, 24 Haymarket, Martlet, and Cambridge Angels.
03-06-2020
Poro Technologies, the Gallium Nitride (GaN) material technology developer and a recent spin-out from the University of Cambridge, has closed a £1.5 million seed round investment to develop a pilot plant in Cambridge and its first major products. The seed round was co-led by Cambridge Enterprise, the commercialisation arm of the University of Cambridge, and IQ Capital Partners, with the...
08-04-2020
Kalium Health, which aims to transform the lives of patients with kidney disease, announces the completion of a seed investment round. Cambridge Enterprise led the over-subscribed round with participation from Kidney Research UK, Cambridge Angels and Martlet Capital, the investment arm of Marshall of Cambridge Group.
13-03-2020
Ajay Chowdhury has been named Chair of the Board of Cambridge Enterprise. He assumed leadership of the Board in January, overseeing the strategy of Cambridge Enterprise, which is tasked with supporting the commercialisation of the ideas that emerge from the University.
06-03-2020
Pages
There are no events to display
There are no jobs to display
No Blog articles found
